Quadrature Capital’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMUX
Quadrature Capital's IMUX Position: Q3 2026 in Review
Quadrature Capital reduced its Immunic (IMUX) stake by 18% in Q3 2026, selling an estimated $92.6K and leaving 31,058 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.
Quadrature Capital first reported a position in IMUX in Q1 2025 and has held it in 4 quarters since. The position peaked at $581K in Q2 2026. 78 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.
- Quadrature Capital held 31,058 shares of Immunic worth $289K as of Q3 2026.
- Quadrature Capital sold 6,728 Immunic shares in Q3 2026, an estimated $92.6K.
- Immunic made up ﹤0.01% of Quadrature Capital's portfolio in Q3 2026, its #1618 holding.
- Quadrature Capital first reported a position in Immunic in Q1 2025 and has held it in 4 quarters since.
- Quadrature Capital's Immunic position peaked at $581K in Q2 2026.
- 78 funds tracked by Wall St. Rank held Immunic as of Q3 2026.
Based on Quadrature Capital's 13F filing for Q3 2026, filed 13 Nov 2026.